Jefferies Drops Coverage of Bio-Reference Labs (BRLI) After TheStreetSweeper Report

Jefferies dropped coverage of Bio-Reference Labs (Nasdaq: BRLI) due to increased
business uncertainties. The firm's latest rating was "Under Review" and our last price target was $21.

"In light of increased business uncertainties, as per our Research Note dated 11/10/11 and titled "Report Puts BRLI Under High-Powered Microscope", in which we referenced an article by TheStreetSweeper, an online research organization, we do not believe we are in a position to provide a recommendation on Bio-Reference Laboratories (BRLI). As a result, we are dropping coverage of the company effective immediately."

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Susquehanna Downgrades Canadian National Railway (CNI) to Neutral
• Trex (TREX) PT Raised to $61 at UBS on Changes to Distribution Network
• ServiceNow (NOW) PT Raised to $115 at UBS as Demand Trends Appear Stable